Related Experiment Video
Updated: Jul 19, 2026

Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Alterations of mitochondrial DNA in CEM cells selected for resistance toward ddC toxicity
M Bjerke1, M Franco, M Johansson
1Mitochondrial Medicine Center, Karolinska Institutet, Stockholm, Sweden. mia.bjerke@ki.se
Abstract:
2 ',3 '-dideoxycytidine (ddC) is a nucleoside analog that has been shown to produce a delayed toxicity which may be due to the depletion of mitochondrial DNA (mtDNA). In order to gain further understanding of the events involved in mitochondrial toxicity, two different CEM cell lines were selected for resistance to the delayed ddC toxicity.
Insights
This study investigates the delayed toxicity of 2
Area of Science:
- Biochemistry
- Molecular Biology
- Toxicology
Background:
- 2',3'-dideoxycytidine (ddC) is a nucleoside analog.
- ddC exhibits delayed toxicity, potentially linked to mitochondrial DNA (mtDNA) depletion.
Purpose of the Study:
- To investigate the mechanisms underlying ddC-induced mitochondrial toxicity.
- To understand the cellular response to ddC toxicity by developing resistant cell lines.
Main Methods:
- Selection of two CEM cell lines resistant to delayed ddC toxicity.
- Analysis of cellular mechanisms conferring resistance to ddC.
Main Results:
- Established CEM cell lines with resistance to ddC toxicity.
- Characterization of the genetic or molecular basis for this resistance.
Conclusions:
- The resistant cell lines provide a model for studying ddC mitochondrial toxicity.
- Further research will elucidate the specific pathways involved in ddC resistance and toxicity.
Related Concept Videos
Treatment Resistant Cancers
Animal Mitochondrial Genetics
